Literature DB >> 3025856

Chimeric antibody with human constant regions and mouse variable regions directed against carcinoma-associated antigen 17-1A.

L K Sun, P Curtis, E Rakowicz-Szulczynska, J Ghrayeb, N Chang, S L Morrison, H Koprowski.   

Abstract

We have cloned the genomic DNA fragments encoding the heavy and light chain variable regions of monoclonal antibody 17-1A, and we have inserted them into mammalian expression vectors containing genomic DNA segments encoding human gamma 3 and kappa constant regions. The transfer of these expression vectors containing mouse-human chimeric immunoglobulin genes into Sp2/0 mouse myeloma cells resulted in the production of functional IgG that retained the specific binding to the surface antigen 17-1A expressed on colorectal carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3025856      PMCID: PMC304173          DOI: 10.1073/pnas.84.1.214

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Sequentially derived mutants of the constant region of the heavy chain of murine immunoglobulins.

Authors:  S L Morrison
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

2.  Physical map of polyoma viral DNA fragments produced by cleavage with a restriction enzyme from Haemophilus aegyptius, endonuclease R-HaeIII.

Authors:  J Summers
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

3.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

4.  Recombinant antibodies possessing novel effector functions.

Authors:  M S Neuberger; G T Williams; R O Fox
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

5.  Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies.

Authors:  M Herlyn; Z Steplewski; D Herlyn; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

6.  Phase II clinical trial of a murine monoclonal antibody cytotoxic for gastrointestinal adenocarcinoma.

Authors:  H F Sears; D Herlyn; Z Steplewski; H Koprowski
Journal:  Cancer Res       Date:  1985-11       Impact factor: 12.701

7.  Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody.

Authors:  D M Herlyn; Z Steplewski; M F Herlyn; H Koprowski
Journal:  Cancer Res       Date:  1980-03       Impact factor: 12.701

8.  Immunochemical characterization of two antigens recognized by new monoclonal antibodies against human colon carcinoma.

Authors:  C Girardet; A Vacca; A Schmidt-Kessen; M Schreyer; S Carrel; J P Mach
Journal:  J Immunol       Date:  1986-02-15       Impact factor: 5.422

9.  Human immune response to multiple injections of murine monoclonal IgG.

Authors:  D L Shawler; R M Bartholomew; L M Smith; R O Dillman
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

10.  Construction of chimaeric processed immunoglobulin genes containing mouse variable and human constant region sequences.

Authors:  S Takeda; T Naito; K Hama; T Noma; T Honjo
Journal:  Nature       Date:  1985 Apr 4-10       Impact factor: 49.962

View more
  28 in total

Review 1.  Generation of recombinant antibodies.

Authors:  S M Kipriyanov; M Little
Journal:  Mol Biotechnol       Date:  1999-09       Impact factor: 2.695

2.  Presentation of the candidate rheumatoid arthritis autoantigen aggrecan by antigen-specific B cells induces enhanced CD4(+) T helper type 1 subset differentiation.

Authors:  Caroline L Wilson; Dominic W Hine; Ariel Pradipta; Jeffrey P Pearson; Willem van Eden; John H Robinson; Andrew M Knight
Journal:  Immunology       Date:  2012-04       Impact factor: 7.397

Review 3.  New and old aspects of immunoglobulin application. The use of intravenous IgG as prophylaxis and for treatment of infections.

Authors:  L Hammarström; C I Smith
Journal:  Infection       Date:  1990 Sep-Oct       Impact factor: 3.553

4.  Genetic engineering of high affinity anti-human colorectal tumour mouse/human chimeric antibody.

Authors:  J Xiang; Z Chen
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

5.  Expression, purification and characterization of a mouse-human chimeric antibody and chimeric Fab' fragment.

Authors:  D J King; J R Adair; S Angal; D C Low; K A Proudfoot; J C Lloyd; M W Bodmer; G T Yarranton
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

6.  Mammalian expression of single chain variable region fragments dimerized by Fc regions.

Authors:  T Kato; K Sato; S Suzuki; H Sasakawa; M Kurokawa; K Nishioka; K Yamamoto
Journal:  Mol Biol Rep       Date:  1995       Impact factor: 2.316

Review 7.  Antibody mediated targeting of radioisotopes, drugs and toxins in diagnosis and treatment.

Authors:  C H Ford; V J Richardson; V S Reddy
Journal:  Indian J Pediatr       Date:  1990 Jan-Feb       Impact factor: 1.967

8.  A humanized antibody that binds to the interleukin 2 receptor.

Authors:  C Queen; W P Schneider; H E Selick; P W Payne; N F Landolfi; J F Duncan; N M Avdalovic; M Levitt; R P Junghans; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

9.  Dose-related comparison of antibody-dependent cellular cytotoxicity with chimeric and native murine monoclonal antibody 17-1A. Improved cytolysis of pancreatic cancer cells with chimeric 17-1A.

Authors:  Y Haga; C L Sivinski; D Woo; M A Tempero
Journal:  Int J Pancreatol       Date:  1994-02

10.  Pharmacokinetics of a mouse/human chimeric monoclonal antibody (C-17-1A) in metastatic adenocarcinoma patients.

Authors:  J M Trang; A F LoBuglio; R H Wheeler; E B Harvey; L Sun; J Ghrayeb; M B Khazaeli
Journal:  Pharm Res       Date:  1990-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.